Article
21q22 balanced chromosome aberrations in therapy‐related hematopoietic disorders: Report from an International Workshop†
11 Mar 2002
Abstract excerpt
The International Workshop on the relationship between prior therapy and balanced chromosome aberrations in therapy-related myelodysplastic syndromes (t-MDS) and therapy-related acute leukemia (t-AL) identified 79 of 511 (15.5%) patients with balanced 21q22 translocations. Patients were treated for their primary disease, including solid tumors (56%), hematologic malignancy (43%), and juvenile rheumatoid arthritis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
